Kazia Therapeutics Limited (KZIA) Social Stream
KAZIA THERAPEUTICS LTD (KZIA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KZIA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued April 11, 2023
Over the past 0 secs, KZIA's average upside potential has been 72.41%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KZIA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KZIA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, KAZIA THERAPEUTICS LTD's number of analysts covering the stock is higher than 15.35% of them.
- In terms of how KAZIA THERAPEUTICS LTD fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 95.49% of that group.
- KAZIA THERAPEUTICS LTD's upside potential (average analyst target price relative to current price) is higher than 529.79% of Pharmaceutical Products stocks.
- KAZIA THERAPEUTICS LTD's average analyst price target is greater than 156.25% of Healthcare stocks.
In the Pharmaceutical Products industry, VYNE, CUE, and ENSC are the three stocks most similar to KAZIA THERAPEUTICS LTD regarding the price target and analyst recommendation information presented here.
Is KZIA a Buy, Hold or Sell? See the POWR Ratings now!